Zacks Small Cap Research on MSN13h
DYAI: CEPI Grants Recognize C1
DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic International Inc. (NASDAQ:DYAI) announced 2024 results and listed a number of accomplishments that will bring both product and grant revenue in the next ...
HealthDay on MSN16h
Longer PSA Monitoring in Patients With Persistent PSA May Reduce Overtreatment
Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate cancer may ...